Our professionals
Dr. Antonio González
Principal Investigator, Translational Oncology Group.
Director, Cancer Center Clínica Universidad de Navarra.
Director of the Department of Medical Oncology.
Medical Oncology Specialist.
Preferred focus on gynecologic oncology.
Works at:
Madrid headquarters
Be part of:
Cancer Center Clínica Universidad de Navarra
Clínica Universidad de Navarra
Cima Universidad de Navarra
Professional career
Medical Degree (MD), Universidad de Navarra, 1993.
Medical Oncology Specialist, Hospital Universitario Ramón y Cajal (Madrid), 1997.
Training stay at The Mount Sinai School of Medicine (New York), 1997.
Attending Physician in Medical Oncology, Medical Oncology Department, Hospital Universitario Ramón y Cajal (Madrid) (1998–2008).
From 2009 to 2017, Head of the Department of Medical Oncology at MD Anderson Cancer Center.
Since September 2017, Co-Director of the Department of Medical Oncology at Clínica Universidad de Navarra and, since 2022, Department Director.
RESEARCH AREAS
- He has served as principal investigator in more than 50 clinical trials and as co-investigator in more than 40 clinical trials, most of them in breast cancer and gynecologic cancer.
- He has served on the Steering Committee of several clinical trials that are currently active: PRIMA and PAOLA-1.
- He has also participated as a collaborating investigator in several funded research projects.
- President of the Spanish Group for Ovarian Cancer (GEICO), a scientific association for clinical and translational research in gynecologic cancer, especially ovarian cancer.
- GEICO representative in the European Network for Gynecological Oncological Trials (ENGOT) and in the Gynecologic Cancer InterGroup (GCIG), an international organization for clinical trials and treatment of gynecologic cancers, where he is currently Chair of the Ovarian Cancer Committee.
AREAS OF INTEREST
- Preferred focus on gynecologic oncology.
Activity
In teaching
- Associate Professor and Course Coordinator for Oncology at Universidad Francisco de Vitoria (Madrid) since 2015 to the present.
- Associate Professor at the University of Texas (2015–2017).
In research
- He has published 90 papers in the field’s most prestigious journals, including high-impact publications in clinical practice in Lancet Oncology, Journal of Clinical Oncology, and New England Journal of Medicine; he has also delivered more than 200 conference communications and presentations at national and international meetings.
- He has written more than 20 chapters on gynecologic cancer, breast cancer, and genitourinary cancer in national and international books and manuals.
- He has been a member of the Editorial Committee of the journal “Clinical and Translational Oncology” since 2007 and Co-Editor of the “Revista de Ginecología Oncológica”.
- He has co-led the organization of the International Gynecologic Cancer Symposium of MD Anderson in Madrid and has been a member of the scientific committee of the biennial symposium “Update in Ovarian Cancer”.

Scientific organizations
- Founding member of the Spanish Ovarian Cancer Research Group (GEICO).
- President of the Spanish Research Group on Ovarian Cancer (GEICO).
- Member of the Spanish Research Group on Breast Cancer (GEICAM).
- Member and Chair of de ovarian committe of the Gynecologic Cancer Intergroup.
- Member of the European Medical Oncology Society (ESMO).
- ESMO Faculty Member for the Gyencological Cancer Group.
Medical advisor of the Association of People Affected by Ovarian Cancer (ASACO). - Member of EUTROC (European Network for Translational Research in Ovarian Cancer).
- Representative of GEICO in ENGOT (European Network for Gynecologic Oncology Trials).